,HNF4α

Céline Van Dender1,2, Steven Timmermans1,2, Ville Paakinaho3

  • 1Center for Inflammation Research, VIB, Ghent, Belgium.

EMBO molecular medicine
|September 11, 2024
PubMed
概括

败血症通过降低肝细胞核因子4α (HNF4α) 来损害肝功能,导致代谢问题和生存率降低. 恢复HNF4α活性为败血症提供了潜在的治疗策略.